Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1991 1
1992 4
1993 4
1994 3
1995 2
1996 1
1998 2
2000 2
2002 1
2003 2
2004 2
2005 2
2008 1
2009 3
2010 2
2011 3
2012 5
2013 6
2014 4
2015 10
2016 7
2017 6
2018 5
2019 1
2020 3
2021 6
2022 5
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.
Hahn C, Budhram A, Alikhani K, AlOhaly N, Beecher G, Blevins G, Brooks J, Carruthers R, Comtois J, Cowan J, de Robles P, Hébert J, Kapadia RK, Lapointe S, Mackie A, Mason W, McLane B, Muccilli A, Poliakov I, Smyth P, Williams KG, Uy C, McCombe JA. Hahn C, et al. Among authors: blevins g. Can J Neurol Sci. 2024 Feb 5:1-21. doi: 10.1017/cjn.2024.16. Online ahead of print. Can J Neurol Sci. 2024. PMID: 38312020 Review.
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group. Vermersch P, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35190477 Free PMC article. Clinical Trial.
Fulminant multiple sclerosis in a 36-year-old man.
Zaeem Z, Emery D, Blevins G. Zaeem Z, et al. Among authors: blevins g. CMAJ. 2022 Jun 6;194(22):E776. doi: 10.1503/cmaj.211807. CMAJ. 2022. PMID: 35667665 Free PMC article. No abstract available.
Sarcoidosis: a prospective observational cohort from Northern Alberta.
Vethanayagam D, Peters J, Saad E, Mulchey K, Gillson AM, McNab B, Farr-Jones M, Hruczkowski T, Blevins G, Coulden R, Oudit G, Beach J. Vethanayagam D, et al. Among authors: blevins g. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020014. doi: 10.36141/svdld.v37i4.8522. Epub 2020 Dec 16. Sarcoidosis Vasc Diffuse Lung Dis. 2020. PMID: 33597801 Free PMC article.
86 results